Duncker Streett & Co. Inc. bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 1st quarter, Holdings Channel.com reports. The firm bought 3,200 shares of the financial services provider’s stock, valued at approximately $555,000.
A number of other large investors have also bought and sold shares of MRSH. Solstein Capital LLC purchased a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $25,000. SHP Wealth Management purchased a new stake in Marsh & McLennan Companies during the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $27,000. Golden State Wealth Management LLC purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $27,000. Finally, Pinnacle Bancorp Inc. bought a new position in Marsh & McLennan Companies during the 1st quarter valued at approximately $28,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on MRSH. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Citigroup raised shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a research report on Wednesday, May 6th. Barclays cut their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Mizuho lowered their price objective on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Finally, Keefe, Bruyette & Woods lifted their price objective on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research report on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $199.25.
Read Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
